Premium
Letter: usefulness of HCC risk scores in HCV patients who fail pegylated interferon/ribavirin
Author(s) -
Chen T.M.,
Lin C.C.
Publication year - 2015
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.13270
Subject(s) - medicine , ribavirin , hepatocellular carcinoma , pegylated interferon , gastroenterology , cirrhosis , hepatitis c virus , hepatitis c , interferon , receiver operating characteristic , oncology , immunology , virus